Home › Kanser sa Cervix › Georgia
Pag-aaral pangklinika para sa Kanser sa Cervix sa Georgia
14 pag-aaral para sa Kanser sa Cervix ang naghahanap ng mga kalahok sa mga site sa Georgia.
Mga Lungsod sa Georgia
Opisyal na teksto ng pag-aaral (English)
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Winship Cancer Institute of Emory University ( Site 5005), Atlanta
- Nancy N. & J.C. Lewis Cancer and Research Pavillion - Research Department ( Site 6005), Savannah
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Nob 6, 2026 · NCT07216703Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Grady Health System Correll Pavilion, Atlanta
- Grady Memorial Hospital Investigational Drug Service, Atlanta
- Emory University Hospital Midtown, Atlanta
- at 4 pa
Nagre-recruitPhase 4
Edad 18 pataas · Kababaihan · Na-update Nob 5, 2026 · NCT06952660Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
- Piedmont Healthcare, Atlanta
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Kababaihan · Na-update Nob 5, 2026 · NCT05051722A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Emory University, Atlanta
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06465069Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Augusta University Georgia Cancer Center, Augusta
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05579366A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Emory University, Atlanta
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06400472A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 114, Atlanta
- Research Site 139, Atlanta
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT05914116Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- Georgia Cancer Center at Augusta University, Augusta
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT06293898Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
- Georgia Cancer Center at Augusta University, Augusta
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Set 10, 2026 · NCT04865887Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Ago 27, 2026 · NCT06492070Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
- Emory University Hospital/Winship Cancer Institute, Atlanta
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
Edad 25 pataas · Kababaihan · Na-update Hul 31, 2026 · NCT07281430A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- Georgian Cancer Center at Augusta University, Augusta
Nagre-recruit
Edad 18 pataas · Kababaihan · Na-update Hul 30, 2026 · NCT04831580First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Winship Cancer Institute, Emory University, Atlanta
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT05768139SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Atlanta
- Massive Bio SYNERGY-AI site, Savannah
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.